Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB
Conditions: Tuberculosis; Hiv Intervention: Drug: Dolutegravir 50 MG Sponsors: University of KwaZulu; Centre for the AIDS Programme of Research in South Africa Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials